New Pain Killer on the Market: Suzetrigine
Guest Article by Dr. Pradeep Chopra Summary What is Suzetrigine? Suzetrigine, marketed under the brand name Journavx, is a novel non-opioid analgesic recently approved by the U.S. Food and Drug Administration (FDA)for the treatment of moderate-to-severe acute pain in adults. Developed by Vertex Pharmaceuticals, Suzetrigine represents the first new class of pain medication approved in […]